Diabetes Mellitus, Type 2 Clinical Trial
— PEDALOfficial title:
Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population
NCT number | NCT04327622 |
Other study ID # | PEDAL |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | March 3, 2020 |
Est. completion date | June 30, 2020 |
Verified date | April 2020 |
Source | LMC Diabetes & Endocrinology Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The study aims to assess foot complications among patients with diabetes in Canada, using patient data collected during diabetes foot assessments performed by the LMC Chiropody Team between February 27, 2018 and April 17, 2019.
Status | Completed |
Enrollment | 5084 |
Est. completion date | June 30, 2020 |
Est. primary completion date | June 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age = 18 years - Diagnosis of type 1 or type 2 diabetes - Under the care of an endocrinologist at LMC - Diabetes foot assessment was performed by the LMC Chiropody Team - Informed consent to use patient medical record data for research purposes was provided Exclusion Criteria: - Prior diabetes foot assessment by an LMC chiropodist |
Country | Name | City | State |
---|---|---|---|
Canada | LMC Healthcare | Toronto |
Lead Sponsor | Collaborator |
---|---|
LMC Diabetes & Endocrinology Ltd. |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Prevalence of diabetes foot complications: foot ulcer | Proportion of patients diagnosed with a foot ulcer | 24-hours | |
Primary | Prevalence of diabetes foot complications: onychocryptosis | Proportion of patients with onychocryptosis | 24-hours | |
Primary | Prevalence of diabetes foot complications: onychomycosis | Proportion of patients with onychomycosis | 24-hours | |
Primary | Prevalence of diabetes foot complications: onychauxis | Proportion of patients with onychauxis | 24-hours | |
Primary | Prevalence of diabetes foot complications: hyperkeratosis | Proportion of patients with hyperkeratosis | 24-hours | |
Primary | Prevalence of diabetes foot complications: foot deformities | Proportion of patients with foot deformities | 24-hours | |
Primary | Prevalence of diabetes foot complications: neuropathy risk | Risk for neuropathy will be measured using the modified Toronto Clinical Neuropathy Score (mTCNS) | 24-hours | |
Secondary | Diabetes foot assessment risk group | Diabetes foot assessment risk group will be determined according to International Diabetes Federation (IDF) recommendations. Proportion of patients with low, moderate, high and very high risk will be reported. | 24-hours | |
Secondary | Association between foot risk variables and the presence of a foot ulcer | Risk factors that are associated with foot ulcers in our patient cohort with diabetes will be reported. | 24-hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |